Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹-134 Cr₹-141 Cr₹-146 Cr₹-134 Cr₹-113 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-134 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹-134 Cr
Mar2025₹-141 Cr
Mar2024₹-146 Cr
Mar2023₹-134 Cr
Mar2022₹-113 Cr

How is Deferred Tax Assets / Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹-134 Cr
Negative
Mar2025 ₹-141 Cr
Negative
Mar2024 ₹-146 Cr
Negative
Mar2023 ₹-134 Cr
Negative
Mar2022 ₹-113 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹46,722.2 Cr -5.7% -7.2% 3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,120.0 Cr -3.2% -7.8% 14.1% Stock Analytics
DIVIS LABORATORIES ₹253,390.0 Cr -3.3% -0.2% 63.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,740.0 Cr -2.4% -5% 33.6% Stock Analytics
CIPLA ₹108,497.0 Cr -4% -5.6% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹100,925.0 Cr -1.2% 4.1% -4.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-5.7%

-7.2%

3.9%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses